Immutep Ltd ADR

Immutep Limited is a biotechnology company. It engaged in developing novel immunotherapy treatments for cancer and autoimmune disease. The company's product pipeline consists of eftilagimod alpha, IMP731, IMP701 and IMP761 which are in clinical stage. It operates primarily in Europe, Australia and the U.S. Immutep Limited, formerly known as Prima BioMed Ltd, is headquartered in Sydney, Australia.

Address Details

Address: LEVEL 12 95 PITT STREET

City: SYDNEY

State: C3

Country: AUS

Zip Code: 2000